Abattis Bioceuticals Corp.
ATTBF
$0.00
$0.000.00%
OTC PK
| 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | 09/30/2018 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.81M | 2.59M | 3.50M | 4.22M | 7.04M |
| Total Receivables | 132.30K | 68.40K | 30.40K | 410.40K | 439.40K |
| Inventory | 202.30K | 215.20K | 22.80K | 22.30K | 23.60K |
| Prepaid Expenses | 572.00K | 685.30K | 700.10K | 645.40K | 593.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.72M | 3.56M | 4.25M | 5.30M | 8.09M |
|
|
|||||
| Total Current Assets | 2.72M | 3.56M | 4.25M | 5.30M | 8.09M |
| Net Property, Plant & Equipment | 571.80K | 524.90K | 528.50K | 520.30K | 560.90K |
| Long-term Investments | 2.39M | 7.53M | -- | -- | -- |
| Goodwill | 2.39M | 7.53M | -- | -- | -- |
| Total Other Intangibles | 8.83M | 3.82M | 3.74M | 3.66M | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 14.55M | 15.60M | 9.82M | 9.64M | 8.82M |
|
|
|||||
| Total Accounts Payable | 166.10K | 180.60K | 161.50K | 168.40K | 172.90K |
| Total Accrued Expenses | 31.60K | 80.20K | 82.10K | 111.40K | 61.60K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 20.50K | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 3.49M | 3.66M | -- | -- | -- |
| Total Other Current Liabilities | 3.49M | 3.66M | -- | -- | -- |
| Total Current Liabilities | 3.71M | 3.92M | 243.60K | 279.70K | 234.50K |
|
|
|||||
| Total Current Liabilities | 3.71M | 3.92M | 243.60K | 279.70K | 234.50K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 93.50K | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.69M | 2.80M | -- | -- | -- |
| Total Liabilities | 6.49M | 6.73M | 243.60K | 279.70K | 234.50K |
|
|
|||||
| Common Stock & APIC | 86.45M | 87.50M | 85.63M | 83.82M | 84.20M |
| Retained Earnings | -76.83M | -77.06M | -74.87M | -74.01M | -77.20M |
| Treasury Stock & Other | -1.26M | -1.26M | -890.20K | -169.90K | 1.89M |
| Total Common Equity | 8.37M | 9.17M | 9.87M | 9.64M | 8.89M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.37M | 9.17M | 9.87M | 9.64M | 8.89M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -309.80K | -299.00K | -292.60K | -286.60K | -302.60K |
| Total Equity | 8.06M | 8.88M | 9.58M | 9.36M | 8.58M |
|
|
|||||